Renamed Coave Therapeutics Raises $39m To Fund Its Next-Gen Gene Therapies

Conjugation Tech Could Improve Gene Delivery

Eye test in France
Rare genetic eye diseases have been among the first targets for pioneering gene therapies. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip